Pharmaceuticals

Microbicides that kill HIV in the lab often fail in clinical trials. A study finds that semen may be the culprit. Cynthia Graber reports

 

Scientific American health and medicine correspondent Dina Fine Maron talks with Armand Sprecher of Doctors Without Borders, who has fought Ebola in Guinea and Liberia. And Steve talks Ebola with Stanford's David Relman, chair of the Forum on Microbial Threats of the Institute of Medicine
 

Research into depression has struggled whereas studies of cancer have thrived. The balance could be shifting

Tainted or sub-standard drugs probably led to the deaths of 13 women after sterilization surgery at a family-planning "camp", and owners of the factories that produced them have been summoned for questioning

An Ebola patient produces up to 40 times more waste than other patients. This and other challenges, including too-small airstrips, complicate the fight against the virus

Scientific American health and medicine correspondent Dina Fine Maron talks about Ebola with tropical medicine and infectious disease expert Daniel Bausch of Tulane University at the annual meeting of the American Society of Tropical Medicine and Hygiene

 

A second form of the painful chikungunya virus has appeared in Brazil—one that could more easily spread, including to the U.S.  

Enough physicians have substance abuse problems to make random drug testing a needed part of medical practice

Diagnostics, vaccines and new drugs could vastly improve the way future Ebola outbreaks manifest in Africa, according to emerging infectious disease expert Jeremy Farrar. Steve Mirsky reports

 

Organizers of tropical medicine meeting to offer refunds, swap out speakers

The number of Ebola cases appear to be dropping in Liberia—but what will it take to stamp out the disease?

A new experiment will study life span extension via an antiaging drug administered to domestic dogs